NTCD-M3, which researchers are readying to phase III clinical trials, was the subject to a separate preclinical study by the...
HONG KONG—An independent panel wrapped up its yearlong examination of China’s treatment of Uyghurs and other ethnic minorities in Xinjiang,...
CEO Neil Clark said: "We have made significant progress since closing the £10.4mln equity funding in December 2020 that enabled...
As of Friday, the Biden Administration has secured a supply of a recently authorized COVID-19 therapeutic treatment, with the U.S....
Carrimycin has become the world's first synthetic biological drug treatment for severe COVID-19 to receive U.S. Food and Drug Administration...
The Centers for Medicare and Medicaid Services has released an interim final rule to remove spending associated with COVID-19 patients from performance...
###About AtosAtos is a global leader in digital transformation with over 110,000 employees in 73 countries and annual revenue of...
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 26,000 deaths worldwide in less than four...
A medicine developed by EU-funded researchers has been approved to treat children with the degenerative and fatal genetic disease Duchenne...
